আন্তর্জাতিক রোগীদের জন্য ভারতে ব্লাড ক্যান্সারের চিকিৎসা

Yes. International patients can share their medical records for a preliminary review by an Indian hematologist or hemato-oncologist before travelling. Depending on the case, the specialist may review blood tests, pathology reports, bone marrow reports, imaging, previous treatment records and current medications before advising the next steps.

Additional tests may be recommended if existing reports are incomplete, outdated or require confirmation. Depending on the diagnosis, these may include blood tests, pathology review, bone marrow examination, imaging, immunophenotyping, or molecular and genetic testing. The exact investigations depend on the patient's individual medical condition.

Yes. An online consultation can allow an Indian hematologist or hemato-oncologist to review available medical records, understand the patient's treatment history and discuss possible treatment pathways. Any final diagnosis or treatment decision may require an in-person clinical evaluation and additional investigations in India.

Patients who have already received treatment can provide their previous medical records, pathology results, treatment protocols, medication history and response records for specialist review. The treating team in India can assess the previous treatment and current disease status before recommending the next appropriate step.

A stem cell transplant may be considered for selected patients depending on the type of blood cancer, disease status, previous treatment, response to therapy and overall health. It is not required for every blood cancer patient. A hematologist or transplant specialist must evaluate the individual case before recommending transplantation.

Selected international patients can be evaluated for CAR-T cell therapy where the appropriate treatment and specialist facilities are available. Eligibility depends on factors such as the specific blood cancer, previous treatments, disease status and overall medical condition. A specialised hemato-oncology or cellular-therapy team must determine whether CAR-T therapy is appropriate.

Patients should provide available medical records such as pathology or biopsy reports, blood-test results, bone marrow reports where applicable, imaging reports and scans, previous treatment summaries, medication details and discharge records. Providing complete records can help the specialist better understand the case and plan the initial evaluation.

The cost varies according to the patient's diagnosis and treatment plan. Factors may include diagnostic investigations, medicines, chemotherapy, targeted or immunotherapy, hospitalisation, supportive care and procedures such as stem cell transplantation or other specialised therapies. A personalised estimate can be provided after the medical team reviews the patient's reports and proposed treatment plan.

The required stay depends on the diagnosis and treatment plan. Some treatments may involve outpatient or day-care visits, while intensive treatment, stem cell transplantation or specialised therapies may require longer hospitalisation and monitoring. The treating hospital can provide an individualised estimate after evaluating the patient's condition and planned treatment.

International patients should ideally complete an initial medical assessment and understand the expected treatment schedule before finalising travel arrangements. Depending on the treatment, the patient may require hospital admission as well as accommodation near the hospital for follow-up appointments. Welltara can assist with hospital coordination, appointments, accommodation and other non-clinical travel support.

Welltara helps international patients coordinate their treatment journey by organising medical records for specialist review, connecting patients with suitable hospitals and specialists, coordinating consultations and appointments, and supporting treatment-related travel arrangements. Diagnosis and treatment decisions remain with the treating doctors and hospital, while Welltara helps simplify the overall healthcare coordination process.